Amlodipine Besylate And Olmesartran Medoxomil Tablet, Film Coated
Product Images NDC 46708-213

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate And Olmesartran Medoxomil (NDC 46708-213). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30's Bottle Pack (Amloolmi 1020mg)

30's Bottle Pack (Amloolmi 1020mg)
Each tablet contains 13.9mg of Amlodipine Besylate USP, equivalent to 10mg of Amlodipine and 2mg of Olmesartan Medoxomil USP. For dosage and usage, refer to the package insert. Store at 15°C to 30°C (59°F to 86°F) and excursions are permitted. This product is manufactured by Aembic Pharmaceuticals Limited in India. NDC code is 46708-214-30. This medication requires a prescription and comes in a package of 30 tablets.*
FDA Label Image

30's Bottle Pack (Amloolmi 1040mg)

30's Bottle Pack (Amloolmi 1040mg)
Each tablet contains 13.9mg of amiodine besylate USP equivalent to 10 mg amiodpine and 4 mg of olmesartan medoxomil USP. Dosage and usage instructions are provided in the package insert. Store at 25°C with excursions permitted to 15°C and 30°C (59°F and 86°F). This product is manufactured by Aembic Pharmaceuticals Limited and is available in 30-tablet packages by prescription only. No further information is available.*
FDA Label Image

30's Bottle Pack (Amloolmi 520mg)

30's Bottle Pack (Amloolmi 520mg)
Each tablet contains 69 mg of Amlodipine besylate USP, equivalent to 105 mg of Amlodipine and 2 mg of Olmesartan medocom USP. The dosage and use information can be found in the package insert. The tablets should be stored at 25°C (77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F) in a USP Controlled Room Temperature. The product is licensed under Mg Lic. No. G959 and has an NDC of 46708-212-30. This information pertains to Amlodipine and Olmesartan Medoxomil Tablets and is manufactured by Alembic Pharmaceuticals Limited. The address of the manufacturer is Village Panelay, P 0. Tajpura, Near Baska, Tk Halol, Panchmate, Gujaa, India.*
FDA Label Image

30's Bottle Pack (Amloolmi 540mg)

30's Bottle Pack (Amloolmi 540mg)
These are Amlodipine and Olmesartan Medoxomil tablets containing 5 mg/40 mg of the respective compounds per tablet. Each tablet is composed of 69 mg of Alodiine Besylate USP, which is equivalent to 105 mg of Amlodipine, and 4 mg of Olmesartan Medoxomil USP. Dosage instructions and directions for use are available in the package insert. Store between 15°C to 30°C (59°F to 86°F). The product is manufactured by Alembic Pharmaceuticals Limited in India. The NDC number is 46708-213-30, and the pack contains 30 tablets.*
FDA Label Image

Amlodipine Besylate (Amloolmi Amlo)

FDA Label Image

Figure 1 (Amloolmi Fig1)

FDA Label Image

Olmesartan Medoxomil (Amloolmi Olmi)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.